ArticleInfection2026
Risk factors and a diagnostic nomogram for early prediction of gram-positive coccal etiology in spontaneous spinal infection.
Article in Infection, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
purposeThis study aimed to identify risk factors associated with Gram-positive (G+) cocci infection in spontaneous spinal infection (SSI) and to develop a practical diagnostic nomogram to support early pathogen-oriented risk stratification before microbiological confirmation.
methodsA retrospective cohort study was conducted on 223 patients with SSI. To ensure robust feature selection while minimizing overfitting, candidate predictors identified from preliminary screening were entered into a LASSO logistic regression model for further selection. The selected predictors were then incorporated into a multivariate logistic regression model to construct the diagnostic nomogram. Model discrimination and calibration were evaluated using the area under the receiver operating characteristic curve (AUC) and calibration curves, respectively. Internal validation was performed via bootstrap resampling (500 iterations). Clinical utility was further assessed using decision curve analysis (DCA) and the clinical impact curve (CIC).
resultsPatients were classified into G+ (n = 101) and non-G+ (n = 122) groups. Fever, history of spinal surgery, C-reactive protein (CRP), albumin (ALB), and the degree of intervertebral space height loss were identified as five independent predictors of G+ infection. The resulting nomogram demonstrated excellent discrimination and good calibration, achieving an AUC of 0.884 (95% CI: 0.841-0.926). DCA and CIC suggested potential clinical value of the model within the present cohort, showing a favorable net benefit across a range of threshold probabilities.
conclusionThe proposed nomogram provides a potentially reliable tool for predicting G+ cocci infection in patients with SSI. By integrating clinical biomarkers and radiologic features, the model enables early prediction of G+ infection and may support preliminary pathogen-oriented risk stratification before microbiological confirmation.
Indexed as
Identifiers
42201512What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.